.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Acute Myeloid Leukemia (AML) management remains challenging, especially in patients with relapsed or refractory (R/R) disease. Recent breakthroughs suggest that the S100A9 inhibitor B2 could provide a new therapeutic strategy. Researchers identified S100A9 as a key driver of disease aggressiveness and suboptimal treatment outcomes. Consequently, targeting this protein may overcome traditional drug resistance mechanisms and improve patient fitness.
The study highlights how S100A9 regulates mitochondrial calcium levels in leukemic cells. B2 binds directly to S100A9 and reduces its overall abundance within the cell. This action triggers a rapid accumulation of mitochondrial calcium. This overload effectively disrupts essential survival pathways, specifically STAT5 and AKT activation. Furthermore, B2 shows high selectivity for S100A9-high AML cells. Importantly, it spares normal hematopoietic cells, which suggests a favorable safety profile for patients undergoing intensive therapy.
Experimental models demonstrated a significant reduction in leukemia burden after treatment with B2. Moreover, transcriptomic data confirmed that the drug effectively attenuates key oncogenic signals. These findings suggest that B2 represents a strong translational candidate for upcoming clinical trials. Thus, it offers a novel approach to targeting mitochondrial vulnerabilities in R/R AML while minimizing off-target effects.
S100A9 is a calcium-binding protein often overexpressed in AML. It is associated with high disease aggressiveness and a poor response to standard chemotherapy and targeted agents.
The S100A9 inhibitor B2 binds to S100A9 and reduces its intracellular abundance. This process induces a lethal accumulation of calcium in the mitochondria, which subsequently inhibits survival signaling and leads to cancer cell death.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Hu C et al. Targeting mitochondrial calcium homeostasis via novel S100A9 inhibitor B2 as a promising agent against AML. J Transl Med. 2026 May 14. doi: 10.1186/s12967-026-08256-1. PMID: 42135826.
Laouedj M et al. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4. Blood. 2017;129(14):1980-1990.
Sheth AI et al. Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium. Cancer Discov. 2024;14(10):1922-1939.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new study identifies B2, a novel S100A9 inhibitor, as a promising treatment for R/R AML by inducing mitochondrial calcium overload in cancer cells....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
